Chris has studied cancer genetics for the best part of ten years. Previously he studied the genetics and pharmacogenetics of colorectal cancer at Cardiff University, identifying genetic loci that contribute to disease development and response to treatment. Four years ago he joined Nitzan Rosenfeld’s lab at the CRUK Cambridge Institute and has since been studying the application of ctDNA to non-invasive cancer detection, for determining patient response to treatment and tracking tumour evolution. Chris also has an interest in studying the bio-physical properties of cell-free DNA in order to unlock yet further clues that will enable us to make the most of this promising biomarker.
Christopher Smith, CRUK
